Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)
Close on Nov 18, 2026Market cap $593.30MP/E –Yield –
Sight Sciences total assets
Total assets on the balance sheet at the end of each period.
Sight Sciences's total assets was $104.87M at Jun 30, 2026. For fiscal 2025 it was $115.30M, down 19.3% from the year before. The highest annual figure on record is $280.19M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $115.30M | -19.3% |
| FY2024 | Dec 31, 2024 | $142.84M | -14.3% |
| FY2023 | Dec 31, 2023 | $166.65M | -21.8% |
| FY2022 | Dec 31, 2022 | $213.07M | -24.0% |
| FY2021 | Dec 31, 2021 | $280.19M | +284.8% |
| FY2020 | Dec 31, 2020 | $72.81M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $104.87M | -14.0% |
| Q1 FY2026 | Mar 31, 2026 | $109.70M | -15.4% |
| Q4 FY2025 | Dec 31, 2025 | $115.30M | -19.3% |
| Q3 FY2025 | Sep 30, 2025 | $116.26M | -19.0% |
| Q2 FY2025 | Jun 30, 2025 | $121.97M | -18.5% |
| Q1 FY2025 | Mar 31, 2025 | $129.68M | -16.6% |
| Q4 FY2024 | Dec 31, 2024 | $142.84M | -14.3% |
| Q3 FY2024 | Sep 30, 2024 | $143.60M | -18.7% |
| Q2 FY2024 | Jun 30, 2024 | $149.72M | -19.2% |
| Q1 FY2024 | Mar 31, 2024 | $155.56M | -20.9% |
| Q4 FY2023 | Dec 31, 2023 | $166.65M | -21.8% |
| Q3 FY2023 | Sep 30, 2023 | $176.64M | -21.6% |
| Q2 FY2023 | Jun 30, 2023 | $185.29M | -23.0% |
| Q1 FY2023 | Mar 31, 2023 | $196.64M | -24.0% |
| Q4 FY2022 | Dec 31, 2022 | $213.07M | -24.0% |
| Q3 FY2022 | Sep 30, 2022 | $225.23M | -22.6% |
| Q2 FY2022 | Jun 30, 2022 | $240.75M | +358.5% |
| Q1 FY2022 | Mar 31, 2022 | $258.59M | +255.2% |
| Q4 FY2021 | Dec 31, 2021 | $280.19M | – |
| Q3 FY2021 | Sep 30, 2021 | $291.05M | – |
| Q2 FY2021 | Jun 30, 2021 | $52.51M | – |
| Q4 FY2020 | Dec 31, 2020 | $72.81M | – |
See a number that looks wrong?